Search
  • Valis Bioscience
    • Nov 12, 2019

Valis co-founder speaks at KRIYA Conference

Valis Co-founder and CSO Dr. Christian Yavorsky spoke last weekend at the Kriya Conference in Northern California. Alongside Dr. Kelley O'Donnell, a researcher and practitioner at NYU, Dr. Yavorsky presented on the standardization of measurement outcomes in ketamine treatment.


Dr. Yavorky's extensive experience in measurement in rapid-acting depressants resulted in a well received presentation and several discussions which may lead to future Valis announcements.


More information regarding the event and topics covered can be found below.

https://www.kriyainstitute.com/schedule-2019/Christian Yavorsky

Recent Posts

See All

Valis attends ACNP Annual Meeting

Last week Valis CEO Ivan Goldensohn attended the American College of Neuropsychopharmacology meeting in Orlando, Florida. The ACNP Meeting (more info at https://acnp.org/) is an invite-only annual mee

Valis Joins CNS Leaders at 10th Annual CNS SUmmit 2019

Valis Bioscience CEO Ivan Goldensohn attended the 10th annual CNS Summit in Boca Raton in late October. A long-time supporter of CNS Summit, Valis is excited to continue supporting CNS Summit and it's

Contact VALIS
ContaCT SUPPORT:
HELP@VALISBIOSCIENCE.com
ContaCT SALES:
SALES@VALISBIOSCIENCE.com

Valis has locations in San Francisco, CA,  Berkeley CA, and New York, NY.

​

Valis Biosciences, Inc.

2111 San Pablo Ave

PO Box 2054

Berkeley California, 94702

  • LinkedIn Social Icon
  • Black Facebook Icon
  • Black Twitter Icon
Privacy Notice
General Inquiries:

Thanks for submitting!

Terms of Use

© 2020 @ Valis Biosciences Inc. All rights reserved.